influenza
Princeton BioMeditech Gets FDA Emergency Use Authorization for Point-of-Care COVID-19, Flu Test
The company recently received a National Institutes of Health grant for an at-home assay to detect both COVID-19 and influenza A and B.
Cue Health Awarded $28M BARDA Contract to Develop Multiplex Respiratory Test
The molecular test would detect and differentiate among influenza A/B, respiratory syncytial virus, and COVID-19 and deliver results within 25 minutes.
BD Gains FDA Clearance for Combination COVID-19, Flu, RSV Molecular Test
The RT-PCR-based BD Respiratory Viral Panel for BD Max received a CE mark in 2022 and FDA Emergency Use Authorization earlier this year.
Co-Diagnostics Awarded $1.2M From NIH RADx Program for Upper Respiratory Panel
The firm's test for influenza A/B, COVID-19, and respiratory syncytial virus runs on its Co-Dx PCR Home testing platform.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
Apr 18, 2023
Apr 12, 2023
Feb 6, 2023
Simple HealthKit Raises $8M in Series A Round
Jan 11, 2023